Dr. Patrick Thompson, M.D.
Claim this profileUniversity of North Carolina
Studies Neuroblastoma
Studies Rhabdomyosarcoma
9 reported clinical trials
24 drugs studied
Area of expertise
1Neuroblastoma
ALK positive
2Rhabdomyosarcoma
Stage IV
PAX/FOXO1 fusion positive
Affiliated Hospitals
University Of North Carolina
University Of North Carolina Lineberger Comprehensive Cancer Center
Clinical Trials Patrick Thompson, M.D. is currently running
Chemotherapy
for Rhabdomyosarcoma
This trial is testing four different chemotherapy schedules for patients with a specific type of advanced cancer. The goal is to find the best way to treat the disease by comparing different timing and combinations of chemotherapy treatments.
Recruiting1 award Phase 2
Oral Irinotecan + Temozolomide
for Pediatric Solid Cancers
This trial is testing a new flavored oral medicine called Orotecan® combined with temozolomide to treat children and young adults with recurring solid tumors. The treatment works by damaging the DNA of cancer cells to stop their growth. Temozolomide has been used in various trials for treating different types of tumors, including gliomas and medulloblastomas.
Recruiting1 award Phase 16 criteria
More about Patrick Thompson, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Patrick Thompson, M.D. has experience with
- Cyclophosphamide
- Dinutuximab
- Temozolomide
- VAL-413
- Azacitidine
- Nivolumab
Breakdown of trials Patrick Thompson, M.D. has run
Neuroblastoma
Rhabdomyosarcoma
Bone Cancer
Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patrick Thompson, M.D. specialize in?
Patrick Thompson, M.D. focuses on Neuroblastoma and Rhabdomyosarcoma. In particular, much of their work with Neuroblastoma has involved ALK positive patients, or patients who are undergoing treatment.
Is Patrick Thompson, M.D. currently recruiting for clinical trials?
Yes, Patrick Thompson, M.D. is currently recruiting for 2 clinical trials in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Patrick Thompson, M.D. has studied deeply?
Yes, Patrick Thompson, M.D. has studied treatments such as Cyclophosphamide, Dinutuximab, Temozolomide.
What is the best way to schedule an appointment with Patrick Thompson, M.D.?
Apply for one of the trials that Patrick Thompson, M.D. is conducting.
What is the office address of Patrick Thompson, M.D.?
The office of Patrick Thompson, M.D. is located at: University of North Carolina, Chapel Hill, North Carolina 27599 United States. This is the address for their practice at the University of North Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.